Endoscopic duodenal-jejunal bypass liner treatment for type 2 diabetes and obesity: glycemic and cardiovascular disease risk factor improvements in 1,022 patients treated worldwide

Ryder, R. E.J. et al. (2023) Endoscopic duodenal-jejunal bypass liner treatment for type 2 diabetes and obesity: glycemic and cardiovascular disease risk factor improvements in 1,022 patients treated worldwide. Diabetes Care, 46(4), e89-e91. (doi: 10.2337/dc22-1952) (PMID:36716004)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Drummond, Dr Russell
Authors: Ryder, R. E.J., Laubner, K., Benes, M., Haluzik, M., Munro, L., Frydenberg, H., Teare, J. P., Ruban, A., Fishman, S., Santo, E., Stengel, R., De Jonge, C., Greve, J. W., Cohen, R. V., Aboud, C. M., Holtmann, G. J., Rich, G., McMaster, J. J., Battelino, T., Kotnik, P., Byrne, J. P., Mason, J. C., Bessell, J., Bascomb, J., Kow, L., Collins, J., Chisholm, J., Pferschy, P. N., Sourij, H., Cull, M. L., Wyres, M. C., Drummond, R., McGowan, B., Amiel, S. A., Yadagiri, M., Sen Gupta, P., Aberle, J., and Seufert, J.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Diabetes Care
Publisher:American Diabetes Association
ISSN:0149-5992
ISSN (Online):1935-5548
Published Online:30 January 2023

University Staff: Request a correction | Enlighten Editors: Update this record